Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|August 12, 2020
Allogeneic stem cell transplantation for patients with aggressive NK-cell leukemiaAyumi Fujimoto, Fumihiro Ishida, Koji Izutsu, et al.
American Journal of Clinical Pathology|September 11, 2020
Simultaneous Discordant B-Lymphoblastic Lymphoma and Follicular LymphomaAyumi Fujimoto, Fumiyoshi Ikejiri, Fumiko Arakawa, et al.
Anticancer Research|November 29, 2023
Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical ProstatectomyYudai Fukui, Yasutaka Yamada, Shinichi Sakamoto, et al.
Scientific Reports|June 27, 2024
Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomyKoichiro Kurokawa, Yasutaka Yamada, Shinichi Sakamoto, et al.
International Journal of Molecular Sciences|July 13, 2024
<i>TNFSF9</i> Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and IpilimumabBunpei Isoda, Shuya Kandori, Tomokazu Sazuka, et al.
Cancer Science|January 8, 2024
L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activityJunryo Rii, Shinichi Sakamoto, Atsushi Mizokami, et al.
Biological & Pharmaceutical Bulletin|December 17, 2016
A Novel Analytical Method of Cisplatin Using the HPLC with a Naphthylethyl Group Bonded with Silica Gel (πNAP) ColumnRyuji Kato, Takaji Sato, Michiko Kanamori, et al.
Leukemia|February 17, 2025
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next studyAyumi Fujimoto, Kana Miyazaki, Kimikazu Yakushijin, et al.
Scientific Reports|June 2, 2021
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2Maihulan Maimaiti, Shinichi Sakamoto, Masahiro Sugiura, et al.
Hematological Oncology|January 19, 2020
Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximabAyumi Fujimoto, Nobuhiro Hiramoto, Satoshi Yamasaki, et al.
Pageof 6